Manuso James S J - Net Worth and Insider Trading

Manuso James S J Net Worth

The estimated net worth of Manuso James S J is at least $37,316 dollars as of 2024-05-22. Manuso James S J is the Director of Ocuphire Pharma Inc and owns about 21,570 shares of Ocuphire Pharma Inc (OCUP) stock worth over $37,316. Details can be seen in Manuso James S J's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Manuso James S J has not made any transactions after 2022-05-20 and currently still holds the listed stock(s).

Transaction Summary of Manuso James S J

To

Manuso James S J Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Manuso James S J owns 2 companies in total, including RespireRx Pharmaceuticals Inc (RSPI) , and Ocuphire Pharma Inc (OCUP) .

Click here to see the complete history of Manuso James S J’s form 4 insider trades.

Insider Ownership Summary of Manuso James S J

Ticker Comapny Transaction Date Type of Owner
RSPI RespireRx Pharmaceuticals Inc 2015-08-18 director & President & CEO
OCUP Ocuphire Pharma Inc 2022-05-20 director

Manuso James S J Latest Holdings Summary

Manuso James S J currently owns a total of 1 stock. Manuso James S J owns 21,570 shares of Ocuphire Pharma Inc (OCUP) as of May 20, 2022, with a value of $37,316.

Latest Holdings of Manuso James S J

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
OCUP Ocuphire Pharma Inc 2022-05-20 21,570 1.73 37,316

Holding Weightings of Manuso James S J


Manuso James S J Form 4 Trading Tracker

According to the SEC Form 4 filings, Manuso James S J has made a total of 2 transactions in Ocuphire Pharma Inc (OCUP) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Ocuphire Pharma Inc is the acquisition of 5,000 shares on May 20, 2022, which cost Manuso James S J around $9,950.

Insider Trading History of Manuso James S J

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Manuso James S J Trading Performance

GuruFocus tracks the stock performance after each of Manuso James S J's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Manuso James S J is 13.15%. GuruFocus also compares Manuso James S J's trading performance to market benchmark return within the same time period. The performance of stocks bought by Manuso James S J within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Manuso James S J's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Manuso James S J

Average Return

Average return per transaction

Outperforming Transactions

1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 1.88
Relative Return to S&P 500(%) 5.68

Manuso James S J Ownership Network

Ownership Network List of Manuso James S J

No Data

Ownership Network Relation of Manuso James S J


Manuso James S J Owned Company Details

What does RespireRx Pharmaceuticals Inc do?

Who are the key executives at RespireRx Pharmaceuticals Inc?

Manuso James S J is the director & President & CEO of RespireRx Pharmaceuticals Inc. Other key executives at RespireRx Pharmaceuticals Inc include SVP of Pre-Clinical Prod. Dev. David Dickason , director & CEO and President Timothy L. Jones , and SVP - Research & Deleopment Purcell Richard David Jr. .

RespireRx Pharmaceuticals Inc (RSPI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of RespireRx Pharmaceuticals Inc (RSPI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of RespireRx Pharmaceuticals Inc (RSPI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

RespireRx Pharmaceuticals Inc (RSPI)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

RespireRx Pharmaceuticals Inc Insider Transactions

No Available Data

Manuso James S J Mailing Address

Above is the net worth, insider trading, and ownership report for Manuso James S J. You might contact Manuso James S J via mailing address: 5130 Route 212, Willow Ny 12495.

Discussions on Manuso James S J

No discussions yet.